fda warning glp-1 october 2025 Beyond the Headlines: Letters to Compounders FDA Achieves Year 1 Goals – FDA Requests Removal of Suicidal

Its in-app community will help you stay motivated and accountable, so its great for people who need a little push

seven of these Eli Lillys hit drug tirzepatide has demonstrated a 94% reduction in the risk of developing type 2 diabetes among overweight and obese prediabetic adults, according to new findings from a 176-week Phase 3 trial

The settlement is widely read as a template: manufacturers now have both regulatory and legal tools to redirect compounding-adjacent telehealth businesses toward authorized distribution channels

Losing muscle not only impacts strength and function but also slows metabolism, making long-term weight maintenance more challenging

Efficacy and cardiovascular safety of GLP-1 receptor analogues

Lets say youre preparing a pound of chicken for four meals